Susan Stewart, director of Blood and Marrow Transplant InfoN

UNITED STATES - MAY 09: Susan Stewart, director of Blood and Marrow Transplant InfoNet, speaks to an expert panel regarding approval of the drug OrBec during a Food and Drug Administration Advisory Committee meeting in Silver Spring, Maryland May 9, 2007. DOR Biopharma Inc. urged U.S. regulators to approve its drug for graft versus host disease, a lethal complication that leukemia patients get after bone marrow transplants. (Photo by Ken Cedeno/Bloomberg via Getty Images)
UNITED STATES - MAY 09: Susan Stewart, director of Blood and Marrow Transplant InfoNet, speaks to an expert panel regarding approval of the drug OrBec during a Food and Drug Administration Advisory Committee meeting in Silver Spring, Maryland May 9, 2007. DOR Biopharma Inc. urged U.S. regulators to approve its drug for graft versus host disease, a lethal complication that leukemia patients get after bone marrow transplants. (Photo by Ken Cedeno/Bloomberg via Getty Images)
Susan Stewart, director of Blood and Marrow Transplant InfoN
EINE LIZENZ KAUFEN
Wie darf ich dieses Bild verwenden?
Fr. 500.00
CHF

DETAILS

Einschränkungen:
Bei kommerzieller Verwendung sowie für verkaufsfördernde Zwecke kontaktieren Sie bitte Ihr lokales Büro.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg’s prior written consent.
Bildnachweis:
Bloomberg / Kontributor
Redaktionell #:
94603584
Kollektion:
Bloomberg
Erstellt am:
9. Mai 2007
Hochgeladen am:
Lizenztyp:
Lizenzpflichtig
Releaseangaben:
Kein Release verfügbar. Weitere Informationen
Quelle:
Bloomberg
Objektname:
pdir0823\PHi_j0186.JPG
Max. Dateigröße:
1600 x 2400 px (13,55 x 20,32 cm) - 300 dpi - 1 MB